The role of endothelium-derived nitric oxide (NO) in the metabolic control of coronary blood flow (CBF) in heart failure (HF) is poorly understood, so the present study investigated the effects of inhibitors of NO synthesis on the response of CBF to changes in myocardial oxygen consumption (MV̇O2) in dogs with HF produced by rapid ventricular pacing and in control dogs. The CBF, MV̇O2, and other hemodynamic parameters were measured in anesthetized animals. Before infusion of Nω-nitro-L-arginine methyl ester (L-NAME), the increases in CBF and MV̇O2 during pacing tachycardia were not significantly different between the control and HF dogs. Intracoronary infusion of L-NAME did not alter the responses of CBF or MV̇O2 to pacing tachycardia in the control dogs, but in the HF dogs, it reduced the CBF response to pacing tachycardia without altering the tachycardia-induced changes in MV̇O2. Intracoronary infusion of L-arginine reversed the effect of L-NAME. These results suggest that in HF dogs NO contributes to the regulation of CBF in response to an increased metabolic demand.
- Endothelium-derived factors
- Heart failure
- Nitric oxide
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine